The SLC35F5 Antibody (PACO38862) is a high-quality polyclonal antibody designed for research involving the SLC35F5 protein. SLC35F5 is a member of the solute carrier family, specifically involved in the transport of nucleotide sugars into the Golgi apparatus for glycosylation processes. This antibody, raised in rabbits, exhibits high reactivity with human samples and has been validated for use in various applications, including Western blot and immunohistochemistry.SLC35F5 plays a crucial role in glycosylation, a post-translational modification essential for the proper function of glycoproteins involved in various cellular processes. Dysregulation of glycosylation pathways, including those mediated by SLC35F5, has been implicated in a range of diseases, including cancer and metabolic disorders.
By targeting SLC35F5, researchers can gain valuable insights into the mechanisms underlying glycosylation and its impact on cellular function.Overall, the SLC35F5 Antibody (PACO38862) is a powerful tool for studying the function and regulation of SLC35F5 in different cell types and tissues. Its specificity and reliability make it an ideal choice for investigations in the fields of biochemistry, cell biology, and glycobiology. By elucidating the role of SLC35F5, researchers can advance our understanding of glycosylation pathways and potentially identify new therapeutic targets for disease intervention. For
Western blot. All lanes: SLC35F5 antibody at 6µg/ml + Hela whole cell lysate. Secondary. Goat polyclonal to rabbit IgG at 1/10000 dilution. Predicted band size: 59, 28 kDa. Observed band size: 59 kDa.
Immunohistochemistry of paraffin-embedded human colon cancer using PACO38862 at dilution of 1:100.
Immunohistochemistry of paraffin-embedded human lung cancer using PACO38862 at dilution of 1:100.
Background:
Putative solute transporter.
Synonyms:
Solute carrier family 35 member F5 (Hepatitis C virus NS5A-transactivated protein 3) (HCV NS5A-transactivated protein 3), SLC35F5, NS5ATP3
